MKS INVESTS LIMITED

Executive Summary

MKS INVESTS LIMITED is a newly formed micro-entity with negligible financial activity and minimal capital, which raises significant concerns about its solvency and operational viability. While regulatory filings are up to date, the lack of substantive financial data and concentrated ownership suggest high risk for investors. Further investigation into the company’s business model and funding is essential before considering investment.

MKS INVESTS LIMITED - Analysis Report

Company Number: 14719588

Analysis Date: 2025-07-29 18:02 UTC

1. Risk Rating: HIGH
   Justification: The company is newly incorporated (less than two years old) with extremely minimal financial activity (current assets and net assets of £1), no employees, and no operational revenues reported. This raises significant concerns regarding its ability to meet obligations and sustain operations.

2. Key Concerns:

• Minimal Financial Substance: The balance sheet shows only £1 in current assets and shareholders’ funds, indicating no meaningful capital or operational capacity.
• Lack of Operational Activity: No employees and no revenue or profit data filed; the company has opted out of filing a profit and loss account, limiting insight into business performance.
• Single Director and Shareholder: Control is concentrated entirely in one individual, which may raise governance and oversight concerns.

3. Positive Indicators:

• Compliance with Filing Requirements: Accounts and confirmation statements are filed on time, demonstrating regulatory compliance to date.
• Clear Ownership and Control: PSC details are transparent, and the sole director is identified with a professional occupation (accountant), potentially indicating competent management.
• Active Status: The company remains active and not in liquidation or administration.

4. Due Diligence Notes:

• Investigate the business model and planned activities to understand why financial activity is so limited.
• Confirm availability of funding sources or capital injections beyond the nominal £1 shown.
• Assess risks related to single-person control and absence of independent directors.
• Seek clarification on the company’s strategy for generating revenue and meeting obligations.
• Review any related party transactions or commitments not reflected in minimal accounts.